Company Directory / research
PrivateFor profitresearchYongin-si, South Korea
iN Therapeutics
iN Therapeutics is a biotechnology platform that develops new drugs for patients suffering from incurable neurological diseases.
- Founded
- 2020 6 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $40B as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
6 years old.
Reach
No web traffic ranking listed.
What it does
BiotechnologyPharmaceuticalTherapeutics
Funding, as listed
$40B currency not stated
- Rounds2
- LatestSeries b, Feb 2022
- Investors10
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about iN Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- iN Therapeutics
- Type
- For profit
- Status
- Private
- Founded
- 2020
- Industry
- research
- Categories
- Biotechnology, Pharmaceutical, Therapeutics
Where
- City
- Yongin-si
- Country
- South Korea
- Markets
- Asia-Pacific (APAC)
Size and reach
- Staff band
- 11-50
Funding, as listed
- Total
- 40,000,000,000 (currency not stated)
- Rounds
- 2
- Latest round
- Series b
- Latest round date
- Feb 2022
- Investors
- 10
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
iN Therapeutics may be growing as evidenced by the industry trends and market projections in the relevant therapeutic sectors. The mRNA therapeutics market, which is related to the biotechnology and therapeutics industry, is projected to reach USD 45.40 billion by 2030, growing at a 1.5% CAGR, indicating a positive trend that could benefit iN Therapeutics. Additionally, the global protein expression market, which is pertinent to drug development in biotechnology, is set for rapid expansion in regions such as North America and APAC. Furthermore, the cell therapy market, which is part of the therapeutic industry, is expected to grow at a 22.67% CAGR till 2033, suggesting a robust growth environment for companies like iN Therapeutics that operate within these sectors.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in South Korea.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 13,309 companies in South Korea and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.